Saveo is a technology company.
Saveo has raised $7.0M across 2 funding rounds.
Saveo has raised $7.0M in total across 2 funding rounds.
Saveo has raised $7.0M in total across 2 funding rounds.
Saveo's investors include RTP Global, Gaurav Munjal, Girish Mathrubootham, Kunal Shah, Roman Saini, Antler, Shift Capital, Venture Catalysts | India's First Integrated Incubator, Guillaume Lestrade, Owen Simonin.
Saveo is a Bengaluru-based B2B technology platform that operates as a managed marketplace for pharmacies in India, connecting pharmaceutical companies with retailers to streamline procurement of generics, surgical supplies, OTC products, specialty medicines, allopathy, and ayurvedic medicines.[1][2][4][6] It serves neighborhood pharmacies by offering faster delivery, cheaper procurement, better technology, live tracking, digital payments, and digitization tools, aiming to ensure no prescription bounces due to stockouts in a fragmented market of 650,000 retailers and 65,000 distributors.[1][2][3] Founded in 2019 as a private limited company, Saveo has raised ₹161.91 Cr ($8.78 Mn+) from investors like Matrix Partners, RTP Global, and Indian Quotient, employs around 173-180 people, and demonstrated strong growth with revenue surging 103X to ₹196.8 Cr in FY24 from ₹1.9 Cr in FY20, while narrowing losses to ₹38.5 Cr.[1][3][4]
Saveo was founded on May 29, 2019, by Vivek Jaiswal, Anurag Savarnya, Shivansh Shrivastava, and Amit Kumar, leveraging their IT expertise to address inefficiencies in India's highly fragmented pharmaceutical supply chain.[2][3] The idea emerged from the need to empower 650,000 micro-entrepreneur pharmacy retailers—unlike the consolidated US model with five major distributors—by creating a single tech-enabled distribution point for primary and secondary medicine markets.[1] Early traction came through building a virtual inventory of 50k+ SKUs from 500+ companies, focusing on timely delivery and digitization, which propelled rapid scaling since inception.[1][2][4][6]
Saveo rides the digitization wave in India's $50B+ pharmaceutical distribution sector, which remains fragmented with inefficient supply chains, by introducing a tech marketplace model that consolidates procurement and empowers local pharmacies.[1][3][4] Timing aligns with rising e-pharmacy adoption post-COVID, government pushes for supply chain resilience, and growth in generics/OTC demand, positioning Saveo to capture share from traditional distributors.[1][4] It influences the ecosystem by enabling smaller manufacturers' access to retailers, fostering sustainability for 650,000 micro-entrepreneurs, and driving sector-wide efficiency amid regulatory tightening on distribution.[1][4]
Saveo is nearing breakeven with controlled costs and promising FY24 metrics, setting up for profitability as it expands carefully in a growing pharma market.[4] Next steps likely include deeper penetration via tech enhancements, potential new funding for national scaling, and riding trends like AI-driven inventory and stricter pharmacy regulations. Its influence could evolve by consolidating market share, inspiring similar B2B healthtech platforms, and transforming how India's pharmacies operate—ultimately making Saveo a cornerstone of resilient pharmaceutical supply chains.[1][4]
Saveo has raised $7.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $3.0M Seed | RTP Global, Gaurav Munjal, Girish Mathrubootham, Kunal Shah, Roman Saini | |
| Jan 1, 2021 | $4.0M Seed | Antler, RTP Global, Shift Capital, Venture Catalysts | India's First Integrated Incubator, Gaurav Munjal, Girish Mathrubootham, Guillaume Lestrade, Kunal Shah, Owen Simonin, Roman Saini |